Clinical Trial Research Updates

Weekly plain-language updates on clinical trial activity, written for patients and caregivers. TrialsAlert publishes research updates every Friday covering the most notable trials across all monitored conditions.

What are clinical trial research updates?

Clinical trial research updates are weekly summaries of new and updated clinical trials published on ClinicalTrials.gov, the world's largest registry of clinical studies. Each update covers a specific medical specialty or condition, highlighting the most significant trials from the past week. Our AI scores each trial across six dimensions — phase importance, breakthrough potential, patient accessibility, condition prevalence, sponsor credibility, and relevance — then classifies them as breakthrough, notable, or routine. The resulting briefings explain what changed, who is sponsoring the research, what phase it is in, and why it matters for patients, all in plain English without medical jargon. These updates serve patients, caregivers, and support communities who want to stay informed about clinical research without spending hours searching databases themselves.

Recent Updates

Immunology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Immunology

RSV Vaccine in Transplant Recipients This Phase 3 trial led by the University Health Network in Toronto is testing a new vaccine designed to protect adult lung and stem cell transplant recipients from...

Urology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Urology

Betadine vs Sterile Water for Periurethral Preparation This Phase 4 trial is exploring whether cleaning the urethra with Betadine or sterile water before inserting a temporary bladder catheter can red...

Rare Diseases Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Rare Diseases

Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency This Phase 3 trial is testing GS-100 gene therapy in children aged 2 to 18 with NGLY1 Deficiency, a rare genetic disorder t...

Autoimmune & Rheumatology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Autoimmune & Rheumatology

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV This Phase 3 trial is testing a new treatme...

Skin Conditions & Dermatology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis This Phase 3 trial is explorin...

Eye Disease & Ophthalmology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Eye Disease & Ophthalmology

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial This Phase 4 trial is exploring whether using atropine eye drops at night can delay the start of nearsightedness in childre...

Kidney Disease & Nephrology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Kidney Disease & Nephrology

Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU This Phase 3 trial studied the drug eculizumab in children suffering from Shiga-toxin related hemolytic ur...

Lung & Respiratory Disease Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Lung & Respiratory Disease

Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2) This large Phase 3 trial tested a new way to use asthma inhalers by combining mainte...

Women's Health & Gynecology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Women's Health & Gynecology

A Mobile Web App Intervention to Promote Cervical Cancer Screening This study is testing a mobile web app designed to encourage cervical cancer screening among Indigenous women aged 25 to 65 on the Ya...

Blood Disorders & Hematology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Blood Disorders & Hematology

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations This phase 3 trial is testing new chemotherapy...

Diabetes & Endocrinology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Diabetes & Endocrinology

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight This Phase 3 study explores two...

Pediatrics & Child Health Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Pediatrics & Child Health

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study This completed study, conducted at multiple sites across the United States, explored a treatment called GM-CSF for childre...

Infectious Disease Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Infectious Disease

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024) This Phase 3 trial examined a new way to pr...

Mental Health & Psychiatry Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Mental Health & Psychiatry

Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury This study from Northwestern University is testing a new digital app designed to support adolescents aged 14 to 18 who engage i...

Orthopedics & Musculoskeletal Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Orthopedics & Musculoskeletal

Tai Chi Intervention for Geriatric Pain Syndrome This study explores a 24-week Tai Chi exercise program aimed at older adults who suffer from chronic pain in multiple areas and have a higher risk of f...

Heart Disease & Cardiology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Heart Disease & Cardiology

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease This large Phase 3 trial is studying inclisiran, a newer injection designed to lowe...

Neurology & Brain Disorders Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Neurology & Brain Disorders

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease This Phase 3 trial is testing donanemab, an intravenous drug, in Chinese people who do...

Cancer & Oncology Clinical Trials Update: Week 19, 2026

May 8, 2026 — 5 trials covered | Cancer & Oncology

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer This phase 3 trial is exploring whether triptorelin can protect the ovaries of adolescent and young adult f...

Immunology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Immunology

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) This Phase 3 study is testing a peanut allergy patch for very young children aged 1 to 3 y...

Autoimmune & Rheumatology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Autoimmune & Rheumatology

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain This Phase 3 trial is testing a new once-week...

Urology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Urology

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging This Phase 3 trial from the University of Alberta is comparing two imaging method...

Rare Diseases Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Rare Diseases

Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy This Phase 3 study by Pfizer focused on a gene therapy treatment for boys with Duchenne Muscul...

Skin Conditions & Dermatology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Der...

Eye Disease & Ophthalmology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Eye Disease & Ophthalmology

Extension Study for the Port Delivery System With Ranibizumab (Portal) This Phase 3 study explores a new implantable device that delivers ranibizumab directly into the eye for people with neovascular ...

Women's Health & Gynecology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Women's Health & Gynecology

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia This large Phase 3 trial led by Imperial College London is studying the effec...

Kidney Disease & Nephrology Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Kidney Disease & Nephrology

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) This Phase 3 trial is testing a new combination pill of BI 690517 with empagliflozin for adults...

Pediatrics & Child Health Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Pediatrics & Child Health

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM This Phase 3 trial is focused on children recovering from complicated severe acute malnutrition ...

Lung & Respiratory Disease Clinical Trials Update: Week 18, 2026

May 1, 2026 — 5 trials covered | Lung & Respiratory Disease

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma This Phase 3 trial is testing tezepelumab, a new biologic medi...

Subscribe to get weekly briefings for your specific condition.